Literature DB >> 10322863

[Relationship between syndrome differentiation-typing and expression of platelet-activation molecule CD62P and CD63 on platelets in psoriatic patients].

G Y Li1, H C Liu, G P Yin.   

Abstract

OBJECTIVE: To understand the relationship between Syndrome Differentiation- Typing and platelet activation in psoriatic patients.
METHODS: Expression of platelet-activation molecules CD62P (alpha-granule membrane glycoprotein) and CD63 (lysosomal integral membrane protein) on platelets from 36 psoriatic patients with Syndrome Differentiation-Typing in TCM and 31 health subjects were investigated by using flow cytometry and specific monoclonal antibodies against activated platelet.
RESULTS: (1) Increased expression of CD62P and CD63 on platelets from psoriatic patients was observed (P < 0.001); (2) The expression of CD62P and CD63 was in following order: The group of Blood Stasis > Blood Dryness > Blood Heat; (3) Compared with the group of Blood Heat, increased expression of CD62P and CD63 was observed in the group of Blood Dryness (P < 0.001); (4) Compared with the group of Blood Dryness, increased expression of CD62P and CD63 was observed in the group of Blood Stasis (P < 0.001).
CONCLUSION: The platelet activation might play an important role in higher blood viscosity, endothelial cell injury, abnormal microcirculation, which was correlated with Blood Stasis, found in psoriasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10322863

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Alternative perspectives: how chinese medicine understands hypercholesterolemia.

Authors:  Kylie A O'Brien
Journal:  Cholesterol       Date:  2010-08-11

2.  DNA Methylation Expression Profile of Blood Heat Syndrome and Blood Stasis Syndrome in TCM Psoriasis.

Authors:  Meng Xing; Ying Luo; Le Kuai; Yi Ru; Xiaojie Ding; Xiaoninng Yan; Bin Li; Xin Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-19       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.